Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Ask your provider for guidance given your specific clinical situation
Results from the SELECT Semaglutide and Cardiovascular Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes trial were presented today during a late-breaking science session at the American Heart Associations Scientific Sessions 2023 and simultaneously published in the New England Journal of Medicine
Gina's lost 25 pounds so far
Resting the injected limb for several minutes after administration allows blood vessels to contract and reduces oozing
"This is not just a health issue for us, it's also an equity issue." Based on data from 2022, 13 per cent of Australian adults have "severe obesity", which is classified as having a BMI of 35 or greater
